Abstract
In January 2006 the US Food and Drug Administration approved the first inhalable insulin preparation for treatment of types 1 and 2 diabetes mellitus. This preparation, marketed by Pfizer, is...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
